31,407 followers
📝論文リンク Dipeptidyl peptidase-4 inhibitors, glucagon-like peptide 1 receptor agonists and sodium-glucose co-transporter-2 inhibitors for people with cardiovascular disease: a network meta-analysis https://t.co/LYXycLkNSd
490 followers
3,446 followers
4,821 followers
@hvanspall @docbhardwaj @JonathanDavisHF @JCardFail @robmentz @dranulala @HFSA @DrMarthaGulati @ShelleyZieroth @vbluml @QuentinYoumans @AndrewJSauer @ShashankSinhaMD @SantosGallegoMD @IRajapreyar @PPirlamarla_MD Not sure, more details are needed. In this C
2,490 followers
Open Access UCL Research: Dipeptidyl peptidase-4 inhibitors, glucagon-like peptide 1 receptor agonists and sodium-glucose co-transporter-2 inhibitors for people with cardiovascular disease: a network meta-analysis https://t.co/GY2bAfUZBb
640 followers
Dipeptidyl peptidase‐4 inhibitors, glucagon‐like peptide 1 receptor agonists and sodium‐glucose co‐transporter‐2 inhibitors for people with cardiovascular disease: a network meta‐analysis. GLP‐1RA and SGLT2i are likely to reduce the risk of CVD mortality.
1,484 followers
RT @rincondesisifo: (Cochrane) Seguridad y eficacia de iDPP4, aGLP1 e iSGLT2 en personas con enfermedad CV establecida https://t.co/LwzcTae…
446 followers
RT @rincondesisifo: (Cochrane) Seguridad y eficacia de iDPP4, aGLP1 e iSGLT2 en personas con enfermedad CV establecida https://t.co/LwzcTae…
262 followers
RT @rincondesisifo: (Cochrane) Seguridad y eficacia de iDPP4, aGLP1 e iSGLT2 en personas con enfermedad CV establecida https://t.co/LwzcTae…
7,496 followers
RT @rincondesisifo: (Cochrane) Seguridad y eficacia de iDPP4, aGLP1 e iSGLT2 en personas con enfermedad CV establecida https://t.co/LwzcTae…
8,473 followers
(Cochrane) Seguridad y eficacia de iDPP4, aGLP1 e iSGLT2 en personas con enfermedad CV establecida https://t.co/LwzcTaekrb Rev Sist y MA reticular https://t.co/xBmipoQqWp
913 followers
RT @CochraneLibrary: The effects of DPP‐4 inhibitors, GLP‐1 receptor agonists and SGLT‐2 inhibitors for people with #CardiovascularDisease…
99 followers
RT @CochraneJapan: DPP-4（ジペプチルペプチダーゼ-4）阻害薬、GLP-1（グルカゴン様ペプチド1）受容体作動薬、およびSGLT-2（ナトリウム-グルコース供役輸送担体-2）阻害薬の心血管病を持つ患者に対する効果 https://t.co/JBBvJIwU…
2,221 followers
DPP-4（ジペプチルペプチダーゼ-4）阻害薬、GLP-1（グルカゴン様ペプチド1）受容体作動薬、およびSGLT-2（ナトリウム-グルコース供役輸送担体-2）阻害薬の心血管病を持つ患者に対する効果 | Cochrane https://t.co/Bm7yc0LKS6
3,522 followers
DPP-4iをいじめるのはそこまでだ🥺
1,792 followers
RT @CochraneJapan: DPP-4（ジペプチルペプチダーゼ-4）阻害薬、GLP-1（グルカゴン様ペプチド1）受容体作動薬、およびSGLT-2（ナトリウム-グルコース供役輸送担体-2）阻害薬の心血管病を持つ患者に対する効果 https://t.co/JBBvJIwU…
295 followers
RT @CochraneJapan: DPP-4（ジペプチルペプチダーゼ-4）阻害薬、GLP-1（グルカゴン様ペプチド1）受容体作動薬、およびSGLT-2（ナトリウム-グルコース供役輸送担体-2）阻害薬の心血管病を持つ患者に対する効果 https://t.co/JBBvJIwU…
1,345 followers
個人的に待望してたSRMAです！ 日本の先生が携わっておられ、その意味でも嬉しいですね😆 ちょうど次回のジャーナルクラブがEMPEROR-Preservedでして、what is knownに使いたいですね。
12,486 followers
RT @CochraneJapan: DPP-4（ジペプチルペプチダーゼ-4）阻害薬、GLP-1（グルカゴン様ペプチド1）受容体作動薬、およびSGLT-2（ナトリウム-グルコース供役輸送担体-2）阻害薬の心血管病を持つ患者に対する効果 https://t.co/JBBvJIwU…
12,591 followers
DPP-4（ジペプチルペプチダーゼ-4）阻害薬、GLP-1（グルカゴン様ペプチド1）受容体作動薬、およびSGLT-2（ナトリウム-グルコース供役輸送担体-2）阻害薬の心血管病を持つ患者に対する効果 https://t.co/JBBvJIwU5c
13,719 followers
Efectos de los inhibidores de la DPP‐4, los agonistas del receptor del GLP-1 y los inhibidores del SGLT‐2 para las personas con #EnfermedadCardiovascular https://t.co/GhDInbIoIn El nuevo metanálisis de la red @CochraneHeart analiza la evidencia de 31 estud
101 followers
RT @Sefap_FAP: (Rev Cochrane) Seguridad y eficacia de los iDPP4, aGLP1 e iSGLT2 en pacientes con enfermedad cardiovascular establecida. htt…
71 followers
RT @Sefap_FAP: (Rev Cochrane) Seguridad y eficacia de los iDPP4, aGLP1 e iSGLT2 en pacientes con enfermedad cardiovascular establecida. htt…
502 followers
RT @Sefap_FAP: (Rev Cochrane) Seguridad y eficacia de los iDPP4, aGLP1 e iSGLT2 en pacientes con enfermedad cardiovascular establecida. htt…
446 followers
RT @rincondesisifo: (Cochrane) Seguridad y eficacia de iDPP4, aGLP1 e iSGLT2 en personas con una enfermedad CV establecida https://t.co/9Rm…
2,508 followers
RT @Sefap_FAP: (Rev Cochrane) Seguridad y eficacia de los iDPP4, aGLP1 e iSGLT2 en pacientes con enfermedad cardiovascular establecida. htt…
7,858 followers
(Rev Cochrane) Seguridad y eficacia de los iDPP4, aGLP1 e iSGLT2 en pacientes con enfermedad cardiovascular establecida. https://t.co/baBnJjAldY
14,570 followers
RT @rincondesisifo: (Cochrane) Seguridad y eficacia de iDPP4, aGLP1 e iSGLT2 en personas con una enfermedad CV establecida https://t.co/9Rm…
8,473 followers
(Cochrane) Seguridad y eficacia de iDPP4, aGLP1 e iSGLT2 en personas con una enfermedad CV establecida https://t.co/9RmtDDuT76 Rev Sist y MA reticular https://t.co/InzqYtHDnh
1,027 followers
Dipeptidyl peptidase-4 inhibitors, glucagon-like peptide 1 receptor agonists and sodium-glucose co-transporter-2 inhibitors for people with cardiovascular disease: a network meta-analysis - PubMed 最新のコクランレビュー https://t.co/EixrjwN8gt
1,398 followers
RT @pinacol: 【コクランレビュー】心血管疾患患者でのDPP-4i、GLP-1RAおよびSGLT2i（DPP-4iはプラセボと比較して全ての有効性転帰のリスクを減少させなかった。GLP-1RAとSGLT2iはプラセボと比較して心血管死亡、全原因死亡リスクを減少させた。…
1,193 followers
RT @pinacol: 【コクランレビュー】心血管疾患患者でのDPP-4i、GLP-1RAおよびSGLT2i（DPP-4iはプラセボと比較して全ての有効性転帰のリスクを減少させなかった。GLP-1RAとSGLT2iはプラセボと比較して心血管死亡、全原因死亡リスクを減少させた。…
1,323 followers
【コクランレビュー】心血管疾患患者でのDPP-4i、GLP-1RAおよびSGLT2i（DPP-4iはプラセボと比較して全ての有効性転帰のリスクを減少させなかった。GLP-1RAとSGLT2iはプラセボと比較して心血管死亡、全原因死亡リスクを減少させた。） #ペ読 https://t.co/FWPpbgiheg
722 followers
RT @CochraneUK: The effects of DPP‐4 inhibitors, GLP‐1 receptor agonists and SGLT‐2 inhibitors for people with #CardiovascularDisease https…
327 followers
RT @CochraneUK: The effects of DPP‐4 inhibitors, GLP‐1 receptor agonists and SGLT‐2 inhibitors for people with #CardiovascularDisease https…
3,368 followers
Diabetes meds for those with #CardiovascularDisease #cardiology #diabetes #healthcare #CVD
71 followers
RT @CochraneLibrary: The effects of DPP‐4 inhibitors, GLP‐1 receptor agonists and SGLT‐2 inhibitors for people with #CardiovascularDisease…
126 followers
RT @CochraneLibrary: The effects of DPP‐4 inhibitors, GLP‐1 receptor agonists and SGLT‐2 inhibitors for people with #CardiovascularDisease…
7,381 followers
RT @CochraneLibrary: The effects of DPP‐4 inhibitors, GLP‐1 receptor agonists and SGLT‐2 inhibitors for people with #CardiovascularDisease…
445 followers
RT @CochraneLibrary: The effects of DPP‐4 inhibitors, GLP‐1 receptor agonists and SGLT‐2 inhibitors for people with #CardiovascularDisease…
80,838 followers
The effects of DPP‐4 inhibitors, GLP‐1 receptor agonists and SGLT‐2 inhibitors for people with #CardiovascularDisease https://t.co/0FwffSCqbC New @CochraneHeart network meta-analysis looks at evidence from 31 studies. #CardiovascularResearch
355 followers
RT @jakub_morze: Our recent awaited @cochranecollab review: Moderate‐to high‐certainty evidence suggest that #GLP1RA and #SGLT2i are likely…
80,838 followers
RT @jakub_morze: Our recent awaited @cochranecollab review: Moderate‐to high‐certainty evidence suggest that #GLP1RA and #SGLT2i are likely…
366 followers
RT @DanielJDrucker: “Future studies conducted in the non-diabetic #CVD population will reveal the mechanisms behind how SGLT2i and GLP1RAs…
147 followers
RT @AtsushiMizuno3: Our Next Cochrane is OUT!! DPP4i, GLP1-RA, and SGLT2i for CVD patients -with NMA- https://t.co/tPJnwSlnTp #cardiotwi…
28,215 followers
RT @DanielJDrucker: “Future studies conducted in the non-diabetic #CVD population will reveal the mechanisms behind how SGLT2i and GLP1RAs…
28,491 followers
“Future studies conducted in the non-diabetic #CVD population will reveal the mechanisms behind how SGLT2i and GLP1RAs improve clinical outcomes irrespective of their glucose-lowering effects” Probably not… #Clinicaltrilsdonotrevealmechanisms https://t.co/
12,402 followers
RT @atmizu: こいつは無茶苦茶疲れたやつ！！ 本当にお疲れ様でした！！ https://t.co/mUP6Cbmj5c
245 followers
Dipeptidyl peptidase-4 inhibitors, glucagon-like peptide 1 receptor agonists and sodium-glucose co-transporter-2 inhibitors for people with cardiovascular disease: a network meta-analysis https://t.co/abl7CjKyKO
147 followers
Our recent awaited @cochranecollab review: Moderate‐to high‐certainty evidence suggest that #GLP1RA and #SGLT2i are likely to reduce the risk of CVD and all‐cause mortality in people with established CVD @CochraneHeart @escardio @EvidenceRobot https://t.co
10,691 followers
RT @atmizu: こいつは無茶苦茶疲れたやつ！！ 本当にお疲れ様でした！！ https://t.co/mUP6Cbmj5c
1,071 followers
RT @AtsushiMizuno3: Our Next Cochrane is OUT!! DPP4i, GLP1-RA, and SGLT2i for CVD patients -with NMA- https://t.co/tPJnwSlnTp #cardiotwi…
19,953 followers
RT @atmizu: こいつは無茶苦茶疲れたやつ！！ 本当にお疲れ様でした！！ https://t.co/mUP6Cbmj5c
9,702 followers
こいつは無茶苦茶疲れたやつ！！ 本当にお疲れ様でした！！ https://t.co/mUP6Cbmj5c
649 followers
Our Next Cochrane is OUT!! DPP4i, GLP1-RA, and SGLT2i for CVD patients -with NMA- https://t.co/tPJnwSlnTp #cardiotwitter #CardioJapan #CardioEd